Jaguar Health Inc (JAGX)
1.20
+0.04
(+3.00%)
USD |
NASDAQ |
Sep 27, 16:00
1.18
-0.02
(-1.67%)
After-Hours: 20:00
Jaguar Health SG&A Expense (Annual): 23.05M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.05M |
| December 31, 2022 | 26.70M |
| December 31, 2021 | 26.00M |
| December 31, 2020 | 21.00M |
| December 31, 2019 | 20.44M |
| Date | Value |
|---|---|
| December 31, 2018 | 22.11M |
| December 31, 2017 | 14.33M |
| December 31, 2016 | 6.469M |
| December 31, 2015 | 6.104M |
| December 31, 2014 | 4.095M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
20.44M
Minimum
2019
26.70M
Maximum
2022
23.44M
Average
23.05M
Median
2023
SG&A Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.06M |
| Alaunos Therapeutics Inc | 12.22M |
| Oragenics Inc | 5.452M |
| Cocrystal Pharma Inc | 5.99M |
| Chimerix Inc | 24.60M |